 Kentaro Yomogida
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 14 | 2023 | 1754 | 1.250 |
Why?
| | Spermatogenesis | 19 | 2013 | 88 | 1.020 |
Why?
| | Muscles | 2 | 2024 | 331 | 0.920 |
Why?
| | Arthritis, Juvenile | 1 | 2025 | 57 | 0.910 |
Why?
| | Testis | 28 | 2008 | 166 | 0.900 |
Why?
| | Synovial Membrane | 1 | 2025 | 137 | 0.850 |
Why?
| | Sertoli Cells | 8 | 2004 | 29 | 0.830 |
Why?
| | Ice | 1 | 2024 | 19 | 0.830 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2023 | 16 | 0.820 |
Why?
| | T-Box Domain Proteins | 2 | 2021 | 102 | 0.720 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 87 | 0.700 |
Why?
| | Perciformes | 1 | 2020 | 19 | 0.640 |
Why?
| | Immunity, Cellular | 1 | 2021 | 267 | 0.630 |
Why?
| | Cryopreservation | 1 | 2020 | 107 | 0.600 |
Why?
| | Transcriptome | 1 | 2025 | 1029 | 0.590 |
Why?
| | Immunity, Innate | 2 | 2021 | 861 | 0.560 |
Why?
| | Interleukin-17 | 2 | 2014 | 125 | 0.480 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 80 | 0.460 |
Why?
| | Mice | 48 | 2024 | 18378 | 0.430 |
Why?
| | DNA-Binding Proteins | 12 | 2008 | 1524 | 0.410 |
Why?
| | Superantigens | 1 | 2013 | 70 | 0.400 |
Why?
| | Th1 Cells | 1 | 2013 | 140 | 0.370 |
Why?
| | Magnetic Fields | 2 | 2024 | 24 | 0.370 |
Why?
| | Streptavidin | 1 | 2012 | 14 | 0.370 |
Why?
| | Cell Polarity | 1 | 2013 | 140 | 0.370 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 203 | 0.360 |
Why?
| | Freezing | 2 | 2024 | 88 | 0.360 |
Why?
| | Animals | 54 | 2025 | 38010 | 0.350 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 144 | 0.350 |
Why?
| | Interferon-gamma | 3 | 2021 | 791 | 0.330 |
Why?
| | Interleukin-2 | 1 | 2012 | 451 | 0.330 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 395 | 0.310 |
Why?
| | Transfection | 9 | 2014 | 949 | 0.290 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1143 | 0.270 |
Why?
| | Infertility, Male | 4 | 2013 | 74 | 0.260 |
Why?
| | Germ Cells | 8 | 2004 | 64 | 0.250 |
Why?
| | Spermatogonia | 7 | 2008 | 15 | 0.250 |
Why?
| | Arthritis, Rheumatoid | 2 | 2025 | 1217 | 0.240 |
Why?
| | Ikaros Transcription Factor | 2 | 2023 | 25 | 0.240 |
Why?
| | Receptor, Notch3 | 1 | 2025 | 8 | 0.240 |
Why?
| | Chemokine CXCL13 | 1 | 2025 | 15 | 0.240 |
Why?
| | Nerve Growth Factors | 2 | 2003 | 79 | 0.240 |
Why?
| | Receptors, CXCR3 | 1 | 2025 | 16 | 0.240 |
Why?
| | Receptors, CXCR5 | 1 | 2025 | 26 | 0.240 |
Why?
| | Intestinal Mucosa | 2 | 2023 | 664 | 0.240 |
Why?
| | Chemokine CXCL9 | 1 | 2025 | 30 | 0.240 |
Why?
| | Electroporation | 2 | 2003 | 40 | 0.240 |
Why?
| | Stromal Cells | 2 | 2025 | 128 | 0.240 |
Why?
| | Mice, Inbred C57BL | 19 | 2023 | 6043 | 0.230 |
Why?
| | Chemokine CXCL12 | 1 | 2025 | 89 | 0.230 |
Why?
| | Spermatozoa | 8 | 2006 | 105 | 0.230 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2621 | 0.220 |
Why?
| | Spondylarthritis | 1 | 2025 | 50 | 0.220 |
Why?
| | Base Sequence | 23 | 2006 | 2199 | 0.210 |
Why?
| | CD8 Antigens | 1 | 2023 | 75 | 0.210 |
Why?
| | Dysbiosis | 1 | 2025 | 182 | 0.200 |
Why?
| | Crystallization | 1 | 2024 | 147 | 0.200 |
Why?
| | Interleukin-15 | 1 | 2023 | 101 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2012 | 2026 | 0.200 |
Why?
| | Haploidy | 8 | 2003 | 28 | 0.190 |
Why?
| | RNA, Messenger | 20 | 2011 | 2852 | 0.190 |
Why?
| | Zinc Fingers | 4 | 2000 | 54 | 0.190 |
Why?
| | Mice, Knockout | 7 | 2023 | 3109 | 0.190 |
Why?
| | Membrane Proteins | 3 | 2021 | 1171 | 0.190 |
Why?
| | Gene Expression Profiling | 3 | 2025 | 1794 | 0.180 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2021 | 7 | 0.180 |
Why?
| | Neuroglia | 1 | 2003 | 173 | 0.180 |
Why?
| | Gene Expression | 7 | 2003 | 1505 | 0.180 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 57 | 0.180 |
Why?
| | Granzymes | 1 | 2021 | 50 | 0.180 |
Why?
| | Cell Nucleus | 7 | 2005 | 612 | 0.170 |
Why?
| | Spermatids | 7 | 2013 | 25 | 0.170 |
Why?
| | Molecular Sequence Data | 21 | 2005 | 2942 | 0.170 |
Why?
| | Cell Differentiation | 13 | 2019 | 2020 | 0.170 |
Why?
| | Fibroblasts | 2 | 2025 | 1044 | 0.170 |
Why?
| | Gene Deletion | 1 | 2021 | 394 | 0.160 |
Why?
| | Receptors, Cell Surface | 1 | 2022 | 379 | 0.160 |
Why?
| | Liver | 3 | 2021 | 1864 | 0.160 |
Why?
| | Green Fluorescent Proteins | 9 | 2005 | 404 | 0.160 |
Why?
| | DNA, Complementary | 8 | 2005 | 277 | 0.150 |
Why?
| | Eosinophils | 1 | 2022 | 325 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 928 | 0.150 |
Why?
| | Palatine Tonsil | 1 | 2019 | 55 | 0.150 |
Why?
| | Transcription, Genetic | 13 | 2008 | 1511 | 0.150 |
Why?
| | Myxoma | 1 | 2018 | 11 | 0.150 |
Why?
| | Antigens, CD | 1 | 2021 | 549 | 0.140 |
Why?
| | Heart Neoplasms | 1 | 2018 | 55 | 0.140 |
Why?
| | Male | 46 | 2025 | 71500 | 0.140 |
Why?
| | Luminescent Proteins | 7 | 2003 | 185 | 0.140 |
Why?
| | Cell Line | 9 | 2014 | 2897 | 0.140 |
Why?
| | Proteins | 5 | 2005 | 1022 | 0.140 |
Why?
| | Heart Atria | 1 | 2018 | 146 | 0.140 |
Why?
| | Macrophages | 1 | 2025 | 1506 | 0.130 |
Why?
| | Seminiferous Tubules | 6 | 2008 | 13 | 0.130 |
Why?
| | 5-Aminolevulinate Synthetase | 2 | 1997 | 2 | 0.130 |
Why?
| | Interleukins | 1 | 2019 | 252 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 732 | 0.130 |
Why?
| | Amino Acid Sequence | 16 | 2005 | 2165 | 0.130 |
Why?
| | Cloning, Molecular | 10 | 2005 | 537 | 0.130 |
Why?
| | Lymphocytes | 1 | 2019 | 398 | 0.130 |
Why?
| | Stem Cells | 5 | 2002 | 619 | 0.130 |
Why?
| | Mice, Mutant Strains | 3 | 2003 | 309 | 0.120 |
Why?
| | Promoter Regions, Genetic | 8 | 2011 | 1263 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 3 | 2008 | 626 | 0.120 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 146 | 0.120 |
Why?
| | Blotting, Northern | 11 | 2003 | 201 | 0.110 |
Why?
| | Immunohistochemistry | 10 | 2013 | 1736 | 0.110 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 14 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2013 | 2542 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 4 | 2013 | 677 | 0.110 |
Why?
| | CD4 Antigens | 1 | 2014 | 146 | 0.100 |
Why?
| | Cell Division | 5 | 2003 | 806 | 0.100 |
Why?
| | Exons | 9 | 2011 | 359 | 0.100 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2013 | 5 | 0.100 |
Why?
| | Acrosome | 1 | 2013 | 6 | 0.100 |
Why?
| | trans-Golgi Network | 1 | 2013 | 15 | 0.100 |
Why?
| | Signal Transduction | 3 | 2025 | 5214 | 0.100 |
Why?
| | Th17 Cells | 1 | 2014 | 109 | 0.100 |
Why?
| | Zymosan | 1 | 2013 | 40 | 0.100 |
Why?
| | Carbolines | 1 | 2013 | 35 | 0.100 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 36 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 82 | 0.100 |
Why?
| | Stem Cell Factor | 3 | 2002 | 17 | 0.100 |
Why?
| | Protein Transport | 2 | 2013 | 447 | 0.100 |
Why?
| | Humans | 26 | 2025 | 143560 | 0.100 |
Why?
| | Culture Media | 1 | 2013 | 165 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 165 | 0.090 |
Why?
| | Microcirculation | 1 | 2013 | 138 | 0.090 |
Why?
| | Biomarkers | 3 | 2021 | 4241 | 0.090 |
Why?
| | Child, Preschool | 2 | 2025 | 11737 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 637 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 367 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 335 | 0.090 |
Why?
| | Quality Improvement | 1 | 2020 | 1263 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.080 |
Why?
| | Spleen | 1 | 2013 | 517 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2008 | 894 | 0.080 |
Why?
| | Nuclear Proteins | 3 | 2003 | 749 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 287 | 0.080 |
Why?
| | Gene Library | 8 | 2003 | 123 | 0.080 |
Why?
| | Actins | 2 | 2003 | 430 | 0.080 |
Why?
| | Meiosis | 2 | 2003 | 95 | 0.080 |
Why?
| | In Situ Hybridization | 8 | 2004 | 321 | 0.080 |
Why?
| | Cytoplasm | 4 | 2005 | 267 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 510 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2013 | 499 | 0.080 |
Why?
| | Histones | 3 | 2006 | 666 | 0.080 |
Why?
| | Female | 16 | 2025 | 77251 | 0.080 |
Why?
| | Heat-Shock Proteins | 3 | 2006 | 140 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2011 | 147 | 0.080 |
Why?
| | Cell Membrane | 1 | 2013 | 708 | 0.080 |
Why?
| | Testicular Neoplasms | 2 | 2003 | 115 | 0.070 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2006 | 41 | 0.070 |
Why?
| | Genes, Reporter | 6 | 2013 | 273 | 0.070 |
Why?
| | Burns | 1 | 2013 | 360 | 0.070 |
Why?
| | Adolescent | 2 | 2025 | 22481 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1130 | 0.070 |
Why?
| | Blotting, Western | 6 | 2013 | 1223 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1192 | 0.070 |
Why?
| | Child | 2 | 2025 | 22725 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4182 | 0.070 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 138 | 0.070 |
Why?
| | Mouth Neoplasms | 1 | 2008 | 89 | 0.070 |
Why?
| | Peptides | 1 | 2013 | 976 | 0.070 |
Why?
| | Response Elements | 2 | 2005 | 89 | 0.060 |
Why?
| | Endoplasmic Reticulum | 2 | 2006 | 263 | 0.060 |
Why?
| | Alternative Splicing | 3 | 2011 | 243 | 0.060 |
Why?
| | Protein Biosynthesis | 5 | 2003 | 453 | 0.060 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 18 | 0.060 |
Why?
| | Cyclic AMP Response Element Modulator | 1 | 2006 | 2 | 0.060 |
Why?
| | Receptors, Androgen | 2 | 2005 | 155 | 0.060 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2006 | 107 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2005 | 7 | 0.060 |
Why?
| | Sperm Tail | 2 | 2002 | 8 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2005 | 1369 | 0.060 |
Why?
| | Chromosome Mapping | 5 | 2011 | 517 | 0.060 |
Why?
| | Gene Targeting | 3 | 2013 | 82 | 0.060 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 4 | 2003 | 15 | 0.060 |
Why?
| | Bacterial Translocation | 1 | 2025 | 48 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 39 | 0.060 |
Why?
| | GATA1 Transcription Factor | 4 | 2003 | 18 | 0.060 |
Why?
| | Mice, Transgenic | 7 | 2005 | 2194 | 0.060 |
Why?
| | Multigene Family | 1 | 2005 | 205 | 0.050 |
Why?
| | Genes | 2 | 2003 | 229 | 0.050 |
Why?
| | Immunity, Mucosal | 1 | 2025 | 99 | 0.050 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 42 | 0.050 |
Why?
| | GATA4 Transcription Factor | 1 | 2004 | 19 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 114 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 2 | 2002 | 247 | 0.050 |
Why?
| | Mitochondrial ADP, ATP Translocases | 1 | 2003 | 2 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 863 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2003 | 55 | 0.050 |
Why?
| | Sperm Count | 1 | 2002 | 21 | 0.050 |
Why?
| | DNA, Circular | 1 | 2002 | 15 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 647 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2003 | 94 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1787 | 0.050 |
Why?
| | Procollagen | 1 | 2002 | 23 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2001 | 397 | 0.050 |
Why?
| | HeLa Cells | 4 | 2006 | 650 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 994 | 0.050 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2002 | 11 | 0.050 |
Why?
| | DNA Damage | 1 | 2005 | 446 | 0.050 |
Why?
| | Spermatocytes | 2 | 2005 | 15 | 0.050 |
Why?
| | Phylogeny | 3 | 2005 | 1008 | 0.050 |
Why?
| | Teratoma | 1 | 2003 | 121 | 0.040 |
Why?
| | Tissue Distribution | 4 | 2004 | 330 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 317 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1487 | 0.040 |
Why?
| | DNA | 5 | 2013 | 1457 | 0.040 |
Why?
| | Immunomodulation | 1 | 2022 | 102 | 0.040 |
Why?
| | Molecular Chaperones | 2 | 2006 | 199 | 0.040 |
Why?
| | Drosophila Proteins | 2 | 2001 | 208 | 0.040 |
Why?
| | Coenzyme A-Transferases | 1 | 2000 | 1 | 0.040 |
Why?
| | Leydig Cells | 2 | 1998 | 15 | 0.040 |
Why?
| | Intestine, Small | 1 | 2022 | 159 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 464 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 330 | 0.040 |
Why?
| | Androgen-Binding Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Ovary | 1 | 2002 | 227 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2002 | 319 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 670 | 0.040 |
Why?
| | Rats | 7 | 1999 | 5610 | 0.040 |
Why?
| | Testicular Hormones | 1 | 1999 | 9 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 225 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2000 | 72 | 0.040 |
Why?
| | Collagen | 1 | 2002 | 457 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2008 | 56 | 0.040 |
Why?
| | Binding Sites | 4 | 2006 | 1325 | 0.040 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 189 | 0.040 |
Why?
| | Protein Isoforms | 3 | 2011 | 404 | 0.040 |
Why?
| | Purpura | 1 | 2018 | 17 | 0.040 |
Why?
| | Prostate | 1 | 2000 | 173 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 554 | 0.040 |
Why?
| | Sequence Analysis, DNA | 4 | 2005 | 823 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 91 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 607 | 0.030 |
Why?
| | Exanthema | 1 | 2018 | 82 | 0.030 |
Why?
| | Luciferases | 3 | 2005 | 152 | 0.030 |
Why?
| | Anemia, Sideroblastic | 1 | 1997 | 4 | 0.030 |
Why?
| | Transferrin | 1 | 1997 | 50 | 0.030 |
Why?
| | Cell Lineage | 1 | 1999 | 368 | 0.030 |
Why?
| | Testosterone | 1 | 2001 | 423 | 0.030 |
Why?
| | Endopeptidases | 1 | 1997 | 81 | 0.030 |
Why?
| | X Chromosome | 1 | 1997 | 69 | 0.030 |
Why?
| | Pyridoxine | 1 | 1997 | 36 | 0.030 |
Why?
| | Fever | 1 | 2018 | 310 | 0.030 |
Why?
| | Erythropoiesis | 1 | 1997 | 56 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 96 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 1997 | 190 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 1998 | 211 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1996 | 65 | 0.030 |
Why?
| | Introns | 4 | 1999 | 255 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 243 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 349 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1999 | 389 | 0.030 |
Why?
| | Echocardiography | 1 | 2018 | 652 | 0.030 |
Why?
| | Crosses, Genetic | 2 | 2008 | 135 | 0.030 |
Why?
| | Microscopy, Fluorescence | 3 | 2000 | 420 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1504 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 1058 | 0.030 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 2013 | 14 | 0.030 |
Why?
| | Sperm Motility | 2 | 2004 | 35 | 0.030 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.030 |
Why?
| | Chemotactic Factors | 1 | 1993 | 43 | 0.020 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.020 |
Why?
| | Dimerization | 2 | 2006 | 197 | 0.020 |
Why?
| | TATA Box | 1 | 1993 | 22 | 0.020 |
Why?
| | Survival | 1 | 2013 | 38 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 1993 | 70 | 0.020 |
Why?
| | Pain | 1 | 2018 | 781 | 0.020 |
Why?
| | Growth Substances | 1 | 1993 | 140 | 0.020 |
Why?
| | Biological Transport | 2 | 2005 | 412 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 403 | 0.020 |
Why?
| | Cricetinae | 2 | 2005 | 300 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1064 | 0.020 |
Why?
| | Aging | 4 | 2008 | 1946 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 326 | 0.020 |
Why?
| | Apoptosis | 3 | 2006 | 2519 | 0.020 |
Why?
| | Rats, Wistar | 1 | 1993 | 454 | 0.020 |
Why?
| | Species Specificity | 2 | 2005 | 577 | 0.020 |
Why?
| | Anemia | 1 | 1993 | 177 | 0.020 |
Why?
| | Random Amplified Polymorphic DNA Technique | 1 | 2011 | 3 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2013 | 504 | 0.020 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 863 | 0.020 |
Why?
| | Blotting, Southern | 2 | 2001 | 83 | 0.020 |
Why?
| | Organ Specificity | 2 | 2002 | 311 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2000 | 52 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 357 | 0.020 |
Why?
| | Mice, Inbred Strains | 2 | 2001 | 408 | 0.020 |
Why?
| | DNA Primers | 2 | 2003 | 518 | 0.020 |
Why?
| | Gestational Age | 1 | 1993 | 970 | 0.020 |
Why?
| | Transcriptional Activation | 2 | 2005 | 380 | 0.020 |
Why?
| | Cell Cycle | 2 | 2005 | 648 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1272 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 748 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 311 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 481 | 0.020 |
Why?
| | Animals, Newborn | 2 | 2003 | 882 | 0.020 |
Why?
| | Cell Movement | 2 | 2004 | 973 | 0.020 |
Why?
| | Fertility | 1 | 2008 | 166 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1998 | 265 | 0.020 |
Why?
| | Neutrophils | 1 | 1993 | 1134 | 0.020 |
Why?
| | Time Factors | 3 | 2004 | 7031 | 0.020 |
Why?
| | Models, Genetic | 2 | 2000 | 593 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2001 | 471 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 2261 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 518 | 0.020 |
Why?
| | Histone Chaperones | 1 | 2006 | 15 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3798 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2006 | 415 | 0.010 |
Why?
| | Cycloheximide | 1 | 2005 | 49 | 0.010 |
Why?
| | Leucine Zippers | 1 | 2005 | 16 | 0.010 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 14 | 0.010 |
Why?
| | Gene Components | 1 | 2005 | 6 | 0.010 |
Why?
| | Hydroxyurea | 1 | 2005 | 34 | 0.010 |
Why?
| | Caspases | 1 | 2006 | 246 | 0.010 |
Why?
| | Bone Marrow | 2 | 1997 | 301 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 36 | 0.010 |
Why?
| | Neurospora crassa | 1 | 2005 | 22 | 0.010 |
Why?
| | Cricetulus | 1 | 2005 | 111 | 0.010 |
Why?
| | Half-Life | 1 | 2005 | 147 | 0.010 |
Why?
| | Metribolone | 1 | 2005 | 5 | 0.010 |
Why?
| | Histidine | 1 | 2005 | 65 | 0.010 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2005 | 39 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 88 | 0.010 |
Why?
| | Adherens Junctions | 1 | 2005 | 24 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 153 | 0.010 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2005 | 27 | 0.010 |
Why?
| | Sperm-Ovum Interactions | 1 | 2004 | 12 | 0.010 |
Why?
| | Glycosylation | 1 | 2005 | 173 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2005 | 193 | 0.010 |
Why?
| | Flagella | 1 | 2004 | 27 | 0.010 |
Why?
| | Fertilization | 1 | 2004 | 44 | 0.010 |
Why?
| | Receptors, Odorant | 1 | 2004 | 32 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 367 | 0.010 |
Why?
| | RNA | 2 | 2001 | 933 | 0.010 |
Why?
| | Chemotaxis | 1 | 2004 | 122 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 215 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 187 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 43 | 0.010 |
Why?
| | Mitochondria | 2 | 2003 | 988 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2005 | 342 | 0.010 |
Why?
| | Ornithine Carbamoyltransferase | 1 | 2003 | 3 | 0.010 |
Why?
| | DNA Replication | 1 | 2005 | 251 | 0.010 |
Why?
| | Protamines | 1 | 2003 | 8 | 0.010 |
Why?
| | Models, Chemical | 1 | 2004 | 273 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 375 | 0.010 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2002 | 6 | 0.010 |
Why?
| | Restriction Mapping | 1 | 2002 | 79 | 0.010 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 11 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2003 | 253 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4522 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 154 | 0.010 |
Why?
| | Base Pairing | 1 | 2002 | 65 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 76 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 474 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 401 | 0.010 |
Why?
| | Genome | 1 | 2005 | 309 | 0.010 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2002 | 19 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 299 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 236 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 179 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 83 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 194 | 0.010 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2001 | 7 | 0.010 |
Why?
| | Argonaute Proteins | 1 | 2001 | 27 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 651 | 0.010 |
Why?
| | Flutamide | 1 | 2001 | 7 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2003 | 165 | 0.010 |
Why?
| | Prostatic Hyperplasia | 1 | 2002 | 41 | 0.010 |
Why?
| | Androgen Receptor Antagonists | 1 | 2001 | 35 | 0.010 |
Why?
| | Dipeptides | 1 | 2001 | 56 | 0.010 |
Why?
| | Mice, Nude | 1 | 2003 | 710 | 0.010 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2000 | 6 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2000 | 97 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 2001 | 187 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2000 | 157 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1781 | 0.010 |
Why?
| | Androgen Antagonists | 1 | 2001 | 92 | 0.010 |
Why?
| | Escherichia coli | 1 | 2005 | 834 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2001 | 317 | 0.010 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2000 | 7 | 0.010 |
Why?
| | Sequence Homology | 1 | 2000 | 44 | 0.010 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2000 | 5 | 0.010 |
Why?
| | Ornithine Decarboxylase | 1 | 2000 | 13 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 32 | 0.010 |
Why?
| | Frameshifting, Ribosomal | 1 | 2000 | 9 | 0.010 |
Why?
| | Pancreas | 1 | 2003 | 333 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2056 | 0.010 |
Why?
| | Polyamines | 1 | 2000 | 44 | 0.010 |
Why?
| | CHO Cells | 1 | 2000 | 166 | 0.010 |
Why?
| | CapZ Actin Capping Protein | 1 | 1999 | 2 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 7153 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3611 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 698 | 0.010 |
Why?
| | Mutation | 2 | 2002 | 4053 | 0.010 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2001 | 213 | 0.010 |
Why?
| | Gonads | 1 | 1999 | 23 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 371 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2000 | 133 | 0.010 |
Why?
| | Inbreeding | 1 | 1999 | 20 | 0.010 |
Why?
| | CpG Islands | 1 | 1999 | 166 | 0.010 |
Why?
| | Stem Cell Transplantation | 1 | 2000 | 187 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1183 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 665 | 0.010 |
Why?
| | Selenoprotein P | 1 | 1998 | 3 | 0.010 |
Why?
| | Mesylates | 1 | 1998 | 6 | 0.010 |
Why?
| | Selenoproteins | 1 | 1998 | 7 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1997 | 9 | 0.010 |
Why?
| | Receptors, LH | 1 | 1997 | 9 | 0.010 |
Why?
| | Cathepsin L | 1 | 1997 | 9 | 0.010 |
Why?
| | Clusterin | 1 | 1997 | 11 | 0.010 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2000 | 341 | 0.010 |
Why?
| | Cathepsins | 1 | 1997 | 24 | 0.010 |
Why?
| | Erythroid Precursor Cells | 1 | 1997 | 5 | 0.010 |
Why?
| | Yolk Sac | 1 | 1997 | 5 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 1997 | 74 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 1999 | 236 | 0.010 |
Why?
| | Aspartic Acid | 1 | 1997 | 82 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1997 | 94 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1507 | 0.010 |
Why?
| | Valine | 1 | 1997 | 80 | 0.010 |
Why?
| | Protein Phosphatase 2C | 1 | 1996 | 16 | 0.010 |
Why?
| | Genetic Markers | 1 | 1997 | 345 | 0.010 |
Why?
| | Protein Phosphatase 2 | 1 | 1996 | 42 | 0.010 |
Why?
| | Conserved Sequence | 1 | 1997 | 242 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3211 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 752 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1996 | 383 | 0.010 |
Why?
| | Glycoproteins | 1 | 1997 | 356 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 1831 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1628 | 0.010 |
Why?
| | Antioxidants | 1 | 1998 | 594 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2000 | 1125 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1416 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1993 | 77 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3380 | 0.000 |
Why?
| | Aged | 1 | 2002 | 25322 | 0.000 |
Why?
| | Middle Aged | 1 | 2002 | 35342 | 0.000 |
Why?
|
|
Yomogida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|